Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Four leading Canadian healthcare providers unite on Sectra's cloud solution to enhance city-wide radiology collaboration and patient care
09 Jun 2026
PR Newswire Association LLC.
How To Strengthen Launch Strategies With Medical-Commercial Collaboration, Upcoming Webinar Hosted by Xtalks
08 Jun 2026
PR Newswire Association LLC.
CMA applauds passage of bill to protect informed patient consent
08 Jun 2026
PR Newswire Association LLC.
Not Just a Headache: Year Three of Pfizer's OOO for Migraine Awareness Campaign Aims to Make Migraine a Visible Priority at Work
08 Jun 2026
GlobeNewswire
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
08 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
PR Newswire Association LLC.
Health Canada authorizes Lunsumio® (mosunetuzumab) for the treatment of relapsed or refractory follicular lymphoma after two or more systemic therapies
08 Jun 2026
PR Newswire Association LLC.
New Progress Toward Public Reimbursement of SKYCLARYS™ for People Living with Friedreich Ataxia in Quebec
08 Jun 2026
PR Newswire Association LLC.
Novus Health Adds Virtual Primary Care to Build Connected Healthcare Assistance Platform
08 Jun 2026
GlobeNewswire
Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
08 Jun 2026
PR Newswire Association LLC.
BCACC launches province-wide 'Practicum Toolkit' to expand clinical counselling / psychotherapy training capacity in British Columbia
08 Jun 2026
PR Newswire Association LLC.
Kye Pharmaceuticals Announces the Availability of Dyanavel® XR Tablets Across Canada for the Treatment of ADHD
08 Jun 2026
PR Newswire Association LLC.
Baycrest Research Highlights Overlooked Condition Affecting People with Advanced Dementia
08 Jun 2026
PR Newswire Association LLC.
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
08 Jun 2026
GlobeNewswire
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
08 Jun 2026
PR Newswire Association LLC.
The Week in Canadian Press Releases: 10 Stories You Need to See
05 Jun 2026
GlobeNewswire
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar
05 Jun 2026
PR Newswire Association LLC.
SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
05 Jun 2026
GlobeNewswire
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
05 Jun 2026
GlobeNewswire
AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness
04 Jun 2026
GlobeNewswire
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial
04 Jun 2026
PR Newswire Association LLC.
LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SaMD)
04 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
GlobeNewswire
Breckenridge Distillery Introduces Breckenridge Rye Whiskey, A Bold New Expression from the World’s Highest Distillery
04 Jun 2026
Upcoming Events All Events
- June 2026
- San Diego: RESI San Diego 2026
- San Diego: BIO 2026
- July 2026
- Taipei: BIO Asia-Taiwan